Article Details

Does PTAB's Ex Parte Cellect Decision Endanger Biopharmaceutical Patent Terms? - Mayer Brown

Retrieved on: 2022-04-20 18:47:01

Tags for this article:

Click the tags to see associated articles and topics

Does PTAB's Ex Parte Cellect Decision Endanger Biopharmaceutical Patent Terms? - Mayer Brown. View article details on HISWAI: https://www.mayerbrown.com/en/perspectives-events/publications/2022/04/does-us-ptabs-ex-parte-cellect-decision-endanger-valuable-patent-terms-of-biopharmaceuticals

Excerpt

This is particularly concerning for makers of biopharmaceuticals, especially immunotherapeutic proteins and other biologic drugs.

Article found on: www.mayerbrown.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up